CORC  > 武汉大学
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies
Wu, Hai-Tao; Yang, Xiao-Jun; Huang, Chao-Qun; Sun, Jian-Hua; Ji, Zhong-He; Peng, Kai-Wen; Zhang, Qian; Li, Yan
刊名WORLD JOURNAL OF SURGICAL ONCOLOGY
2016
卷号14
关键词Lobaplatin Docetaxel Peritoneal carcinomatosis Cytoreductive surgery Hyperthermic intraperitoneal chemotherapy
ISSN号1477-7819
DOI10.1186/s12957-016-1004-4
URL标识查看原文
收录类别SCIE
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4049357
专题武汉大学
推荐引用方式
GB/T 7714
Wu, Hai-Tao,Yang, Xiao-Jun,Huang, Chao-Qun,et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies[J]. WORLD JOURNAL OF SURGICAL ONCOLOGY,2016,14.
APA Wu, Hai-Tao.,Yang, Xiao-Jun.,Huang, Chao-Qun.,Sun, Jian-Hua.,Ji, Zhong-He.,...&Li, Yan.(2016).Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.WORLD JOURNAL OF SURGICAL ONCOLOGY,14.
MLA Wu, Hai-Tao,et al."Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies".WORLD JOURNAL OF SURGICAL ONCOLOGY 14(2016).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace